NASDAQ:MCRB - Seres Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$6.00 -0.11 (-1.80 %)
(As of 02/20/2019 05:59 AM ET)
Previous Close$6.11
Today's Range$5.80 - $6.24
52-Week Range$4.42 - $10.32
Volume114,800 shs
Average Volume125,063 shs
Market Capitalization$245.16 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Seres Therapeutics (NASDAQ:MCRB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Seres Therapeutics in the last 12 months. Their average twelve-month price target is $15.3333, suggesting that the stock has a possible upside of 155.56%. The high price target for MCRB is $16.00 and the low price target for MCRB is $15.00. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.502.502.71
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $15.3333$15.3333$15.3333$19.25
Price Target Upside: 155.56% upside92.63% upside72.67% upside159.78% upside

Seres Therapeutics (NASDAQ:MCRB) Consensus Price Target History

Price Target History for Seres Therapeutics (NASDAQ:MCRB)

Seres Therapeutics (NASDAQ:MCRB) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2019CowenReiterated RatingBuyLowView Rating Details
11/23/2018Cantor FitzgeraldReiterated RatingOverweightHighView Rating Details
11/9/2018OppenheimerSet Price TargetBuy$16.00HighView Rating Details
10/28/2018Chardan CapitalReiterated RatingBuyMediumView Rating Details
8/3/2018Bank of AmericaDowngradeNeutral ➝ UnderperformHighView Rating Details
10/13/2017CIBCInitiated CoverageOutperform ➝ Outperform$19.00N/AView Rating Details
10/12/2017CitigroupInitiated CoverageOutperform ➝ Positive$19.00N/AView Rating Details
10/6/2017Seaport Global SecuritiesReiterated RatingBuy$20.00N/AView Rating Details
8/4/2017HC WainwrightReiterated RatingBuy ➝ Buy$15.00 ➝ $19.00HighView Rating Details
8/3/2017Canaccord GenuitySet Price TargetBuy$20.00LowView Rating Details
3/20/2017FBR & CoReiterated RatingOutperform$18.00LowView Rating Details
(Data available from 2/20/2017 forward)
This page was last updated on 2/20/2019 by Staff

Featured Article: What is a balanced fund?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel